Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
about
The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.Polymer-conjugated inhibitors of tumor necrosis factor-α for local control of inflammationPediatric Psoriasis.Extracellular matrix molecules: potential targets in pharmacotherapy.Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis.Comparison of release and penetration of tacrolimus ointment reference and trial formulation after dermal application to pigs by liquid chromatography-electrospray ionization tandem mass spectrometry.Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitisCalcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.Long-term safety of tacrolimus ointment in children treated for atopic dermatitis.Therapeutic potential of macrolide immunosuppressants in dermatology.Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases.The mode of topical immunomodulators in the immunological network of atopic dermatitis.The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus.Netherton syndrome: a case report and review of the literature.The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.Systemic ciclosporin and tacrolimus in dermatology.Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.The Role of Methionine Oxidation/Reduction in the Regulation of Immune Response.The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response.Macrolide therapy in chronic inflammatory diseases.Tacrolimus ointment in the management of atopic dermatitis.Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction.Pimecrolimus reduces eosinophil activation associated with calcium mobilization.Case Report: Solitary mastocytoma treated successfully with topical tacrolimus.Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus.Facial lichen striatus: successful treatment with tacrolimus ointment.[Topical corticosteroids versus topical inhibitors of calcineurin].Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia.Improved therapy for atopic eczema. New immunomodulators clear the rash with few side effects.Treatment of oral lichen planus with topical pimecrolimus 1% cream.Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model.Successful treatment of pityriasis lichenoides with topical tacrolimus.Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: a prospective non-controlled case series.Unsuccessful treatment of extragenital lichen sclerosus with topical 1% pimecrolimus cream.Pimecrolimus for treatment of acne rosacea.Pimecrolimus 1% cream in the treatment of disseminated granuloma annulare.
P2860
Q25256724-3C39DB16-3A9D-4FAE-8A4D-4CE92228E7A0Q26852346-7057423E-D653-4C8A-8DA7-494A05ACCF77Q30234370-48F23266-358E-44A5-AE63-6B49C8EAC03AQ33694487-7E396F0F-F99A-4A4C-9B5D-071918B5F7F1Q33807278-20E194B9-631D-41DB-BCC4-444730856FCFQ34711615-CE5AB1BE-ED41-4601-B88A-BE31C1BE4422Q34735206-E5A35267-EE0B-4399-A305-6D5901B0EF0BQ34882570-90FFB70A-AA92-480C-8DDD-1AFC097EE074Q35015840-B976EDF6-9278-4C6F-A64F-0B6295B8D8F2Q35208400-A7E96D0B-9C56-4881-B317-46C7BB1110FCQ35680649-6233511C-2F32-4DA0-8F98-A1207B32CEE7Q35922000-4F7D8303-CE94-45C8-9168-308125AAE47CQ36051518-71CD3718-B94B-447E-86DE-DABF841FAE58Q36487720-78F63D1F-F771-4760-A6FF-F5FA2F8F1426Q36516949-E3C32BBE-4212-49F1-B202-F9111580CA56Q36940038-D8D6F569-E07E-49F2-9D99-6D28E4B4A8B0Q36986032-3BD87721-7602-43DB-84A0-A16A8BBEE1A5Q37327264-EE51628D-1FB1-4398-B77F-63B12B6F8547Q37613487-88CFB92D-F2F0-45E0-BDF4-6D16FF1BD925Q41835286-E4888157-3B75-4DB8-B172-095D2C78F41AQ42016590-7CB4D8E3-A6FD-4A62-AA34-60D69D363094Q42081579-3E771C39-C4DD-4D97-810D-6240F04D6488Q42516469-46F0B144-5A03-45ED-86F4-566E6E415B73Q42643465-90A91D5B-E4A4-4576-87D9-E11045BD14AAQ42864767-A47DAA06-F457-4C32-90F6-73F5CED3A378Q44316618-6BF2B1F1-0915-42F7-89D0-0ED69062D9C2Q44373545-5799BCDD-8E6F-45A6-807D-AAB93CCBC5B6Q44386076-FDF193E5-19EC-46C8-989E-4E6ECDE42EE1Q44492804-390D2D97-987C-4BF5-BB3F-C9BB99D0546DQ44699166-6562A26D-52DD-4052-83D5-D0A20173A1ABQ44750949-50E19639-AF22-488A-B433-B1B44FC04630Q44852574-AA7D9780-6917-4BA0-B7A8-DD7962942659Q44871871-C2DE965F-5625-49FD-9AFD-32657C994985Q44900542-6DF3CAB5-6276-4366-8F30-88EDED669E53Q45120688-39D80CFB-699D-433F-AACE-019D3111717AQ45278090-CBAD6796-D8C6-4FEA-9187-DB9A7075218FQ46152800-E828C5D3-C139-4872-89BE-195D851F6915Q46413499-DEAAB272-5BD4-459C-8979-F1D761DD4E9EQ46488227-FBA40798-B093-4FE2-80C3-63B9630E19EAQ46539298-35B64F02-6FF4-4AFF-82F0-A5B3E87C55BB
P2860
Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@ast
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@en
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@nl
type
label
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@ast
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@en
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@nl
prefLabel
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@ast
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@en
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@nl
P2093
P356
P1476
Tacrolimus and pimecrolimus: f ...... nd treating atopic dermatitis.
@en
P2093
Greg Pearson
Paul Nghiem
Richard G Langley
P304
P356
10.1067/MJD.2002.120942
P407
P577
2002-02-01T00:00:00Z